California Resources Corp has undergone a transformative scale-up via the Aera acquisition, with revenue surging 58% YoY to $1.3B in 2026Q2, but this growth is tempered by regulatory constraints and earnings volatility. The company's balance sheet remains cons...
Price trend, volume and key moving averages
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 10, 2026 | $0.99-27.2% vs $1.36 | $1.3B+35.1% vs $960M |
Q2 2026 May 5, 2026 | $0.88+6.0% vs $0.83 | $119M-87.4% vs $947M |
Q2 2026 Mar 2, 2026 | $0.47-4.1% vs $0.49 | $924M+18.9% vs $777M |
Q4 2025 Nov 4, 2025 | $1.46+11.5% vs $1.31 | $878M+12.5% vs $781M |
CRC plans to sell its non-core Uinta Basin assets for about $90 million, freeing cash to support its California-focused strategy and capital allocation.
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Medicines Agency's Committee for Medicinal Products for Hu
LONG BEACH, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) today announced the signing of an agreement to divest its Uinta Basin assets to an undisclosed buyer for total cash consideration of approximately $90 million, subject to customary purchase price adjustments.
Summit Therapeutics Inc. (NASDAQ: SMMT) today noted that its partner Akeso Inc. [url="]announced[/url] that updated data, including overall survival (OS), from
Benchmark CRC against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for California Resources Corp (CRC)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $52.10 | $4.63B | 12.55 | 21.88% | 10.07% | 10.07% | 2.99% | |
| $27.38 | $2.34B | 3.24 | 49.76% | 13.56% | 9.55% | — | |
| $34.31 | $8.23B | 6.08 | 18.07% | 18.16% | 16.53% | — | |
| $52.12 | $6.47B | 8.56 | 5.1% | 18.6% | 12.05% | — | |
| $13.18 | $4.35B | 24.41 | 22.14% | 1.27% | 1.12% | — | |
| $1.10 | $24.22M | -0.49 | -14.92% | -24.51% | -29.92% | — |
California Resources Corp (CRC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
California Resources Corp (CRC) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 10, 2026·SEC
Jul 14, 2026·SEC
Jun 26, 2026·SEC
Get notified when CRC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
California Resources Corp (CRC) stock FAQ — growth, dividends, profitability & financials explained
California Resources Corp (CRC) reported $4.01B in revenue for fiscal year 2025. This represents a 1% decrease from $4.07B in 2012.
California Resources Corp (CRC) grew revenue by 21.9% over the past year. This is strong growth.
California Resources Corp (CRC) reported a net loss of $121.0M for fiscal year 2025.
Yes, California Resources Corp (CRC) pays a dividend with a yield of 2.99%. This makes it attractive for income-focused investors.
California Resources Corp (CRC) has a return on equity (ROE) of 10.1%. This is reasonable for most industries.
California Resources Corp (CRC) generated $395.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
